Advanced Therapies Week
9 January 202612 January 2026
California, USASan Diego Convention Center
A major partnering and insights event for the cell and gene therapy ecosystem, bringing together stakeholders across R&D, therapeutic development and advanced manufacturing.
Across four days in San Diego, the programme combines strategic content with extensive networking designed to connect companies, investors, and solution providers shaping the future of advanced therapies. Alongside conference sessions, the event supports year-start relationship building across the CGT value chain—from early research through commercial-scale delivery.
Who the audience is and how many attend
Audience
- Biotech and pharma leaders in cell and gene therapy R&D and development
- Advanced manufacturing and CMC teams, CDMOs and enabling technology providers
- Investors and strategic partners active in advanced therapies
- Academics, regulators and broader CGT stakeholders
Scale
- Attendees: 2,000+
- Sponsors & exhibitors: 200+
What to expect
- A four-day, in-person programme with content spanning cell & gene therapy strategy, development and manufacturing
- High-density networking designed to support partnering, fundraising and commercial collaboration
- A substantial sponsor and exhibitor floor for meeting solution providers and manufacturing partners
- Community touchpoints and structured networking opportunities that make it easy to meet the right people quickly
Latest Features
9 December 2025
Today's issue
Company Spotlight
A TechBio company that specializes in developing personalized vaccines and immunotherapies through its advanced AI-Immunology™ platform. The company bridges artificial intelligence technology, bioinformatics, and drug development to bring novel immunotherapies to patients facing cancer and infectious diseases.
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze